When patients with hematologic or other intractable disorders need to undergo allogeneic HSCT (hematopoietic stem cell transplantation), related family members are most often considered as candidates for the hematopoietic stem cell (HSC) donation. According to a nationwide questionnaire survey in Japan, 98.0% of family donors are informed about the HSC donation procedure only by the clinicians involved in the care of the HSC transplant recipient ('recipient clinicians'). Moreover, when written informed consent for HSC donation was obtained, the recipient clinicians and the recipients themselves were present with the prospective donors in 89.3 and 70.7% of cases, respectively. 1 We questioned whether in such situations the donors were truly agreeing to donate of their own free will, and whether their safety in terms of physical eligibility was considered sufficiently. There have been many studies on the safety and ethical issues facing unrelated volunteer HSC donors 2, 3 and especially on issues regarding PBSC collection. [4] [5] [6] However, surprisingly, few studies so far have addressed these issues with special reference to related donors. 7 Therefore, we started a unique donor consultation program, 'Consulting Clinic for Related HSC Donors (CRD),' in which two clinicians ('donor clinicians') who are not directly involved in the care of the prospective recipients play a central role in securing the rights and safety of related family donors. We herein introduce the CRD process at our hospital (Figure 1 ). At the CRD visit, the donor candidate watches a video program to obtain general information about HSCT and completes a questionnaire to elicit a medical history. Then the donor clinician comprehensively explains what HSC donation is, especially focusing on the risks associated with BM and PBSC harvesting in addition to their potential alternatives. After the written informed consent for the donation is obtained, the donor candidate undergoes unified medical examinations to evaluate eligibility for the planned HSC donation; thereafter, the donor clinician and another physician who is also uninvolved in the care of the prospective recipient meet together and discuss whether the examination results satisfy our institutional eligibility criteria. Decisions are classified into three groups: (A) 'qualified', (B) 'reserved' (requesting more consideration) and (C) 'unqualified'. The patient is informed of the decision by the recipient clinician, who reports that the donor candidate is 'qualified' or 'unqualified' without disclosing the reasons, while the donor candidate is (Table 1) . Two candidates were judged as 'unqualified' at the first medical interview. Sixtyeight qualification meetings by two clinicians were held to judge the eligibility of the candidates to undergo BM or PBSC donation; the initial decisions were 'qualified' in 43 cases (63%), 'reserved' in 21 (33%) and 'unqualified' in 4 (6%). The reasons for reservation were abnormalities in blood or urine examinations in 17 cases, suspicion of cardiovascular disease in 3 and suspicion of a neurological disorder in 1. The reasons for disqualification were suspicion of malignant tumors in three cases and presence of cardiovascular disease in one. Twenty of twenty-one candidates (95%) in the 'reserved' group were eventually judged 'qualified' after existing diseases were controlled and/or the donor was re-evaluated by another consultant physician or anesthesiologist. Three of four 'unqualified' candidates at the first CRD were reclassified as 'qualified' at the second CRD when the requested source of HSC was changed from PBSC to BM. Twelve of sixty-six 'finally qualified' donors (18%) did not actually donate HSCs due to various reasons, including death of the recipient before undergoing HSCT. To date, we have not observed any severe adverse events in the remaining 54 donors who actually donated HSC, with a median follow-up of 33 months (range, 5-51 months).
It is still difficult to estimate the contribution of our CRD to the improvement of donor safety because our experience is limited. However, we believe that our CRD has a meaningful impact on the ethical issues facing related donors. The psychological condition of the donor, particularly the donor's motives for considering the HSC donation, should be carefully assessed prior to giving informed consent. It is reported that family donor candidates may occasionally be subjected to coercion or external pressure, partly because such donors' desire to help relatives may be different from the motivations of unrelated donors. 8, 9 In a survey of Japanese HSCT centers, 39.4% of related donors felt that they could not refuse to donate, while only 20% of them felt that they had a chance to refuse to donate HSCs if they did not want to do so. 1 Especially, in case the donor candidate is a child and the prospective recipient is one of their parents, there is a clear conflict of interest since the parent usually signs the consent for the child, raising a strong need for a guardian of the child donors.
In our CRD, several donor candidates hesitated over whether to agree or to refuse to donate. In those cases, the donor clinicians informed the candidate that even if the donation is refused, they would never tell the patient why the donor candidate could not donate HSC. This system largely put the candidates at their ease, and all of these candidates finally agreed to donate. Switzer et al. 10 reported that unrelated donors who felt they were pressured, irrespective of whether they were encouraged or discouraged to donate, are less likely to have a positive donation experience. In this way, our CRD program functioned as a buffer zone for the relationship between the donor and recipient.
In conclusion, we believe that this type of CRD program, which supports and respects the donors' free will, should become more widely used to secure the rights and safety of related donors. Further studies on the role of the CRD in the management of related familial donors are warranted. 
